Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Special Issue July 2020

Convolutional Neural Network Based on Fluorescein Angiography Images for Retinopathy of Prematurity Management

PDF

Domenico Lepore; Marco H. Ji; Monica M. Pagliara; Jacopo Lenkowicz; Nikola D. Capocchiano; Luca Tagliaferri; Luca Boldrini; Vincenzo Valentini; Andrea Damiani; for the FA Team of the Italian ROP Study Group
TAGS: angiogram, convolutional neural networks, fluorescein, fluorescein angiography, retinopathy of prematurity, eye
Trans. Vis. Sci. Tech.. 2020; 9(2):37. doi: https://doi.org/10.1167/tvst.9.2.37

ARVO Annual Meeting Abstract July 2019

Photodynamic therapy for the treatment of choroidal metastasis: a retrospective study

Giulia Midena; Monica M Pagliara; maria grazia sammarco; Andrea Scupola; Martina Maceroni; Carmela Grazia Caputo; Maria Antonietta Blasi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3551. doi:

ARVO Annual Meeting Abstract July 2018

Correlation of clinico-pathological features and whole-genome sequencing analysis by array CGH for uveal melanoma

Gabriela Grimaldi; Andrea Scupola; Maria Grazia Sammarco; Maria Antonietta Blasi; Monica Maria Pagliara; Maria Emanuela Toro; marcella zollino; Daniela Orteschi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4321. doi:

ARVO Annual Meeting Abstract July 2018

Adjuvant high-dose rate (HDR) brachytherapy for ocular tumours with orbital invasion

Monica Maria Pagliara; Luca Tagliaferri; Angela Lanza; Luigi Azario; Gustavo Savino; Rosa Autorino; andrea scupola; Vincenzo Valentini; Maria Antonietta Blasi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5605. doi:

ARVO Annual Meeting Abstract April 2014

EDI-OCT for early evaluation of recurrence after ruthenium brachitherapy for choroidal melanoma

Monica M. Pagliara; Maria Grazie Sammarco; Francesca Leonardi; Andrea Scupola; Caputo G Carmela; Aldo Caporossi; Maria Antonietta Blasi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5088. doi:

ARVO Annual Meeting Abstract March 2012

Brachytherapy with Iodine 125 or Ruthenium 106 for treatment of choroidal melanomas measuring 5-7 mm in thickness

Maria A. Blasi; Monica M. Pagliara; Luca Tagliaferri; Carmela G. Caputo; Antonio Villano; Emilio Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3404. doi:

ARVO Annual Meeting Abstract March 2012

Evaluation of the Effects of Intravitreal Injection of Bevacizumab on Controlateral Eye Treated with Conventional Laser Photoablation

Fernando Molle; Domenico Lepore; Antonio Baldascino; Pierdavide Perrini; Lorenzo Orazi; Monica M. Pagliara; Velia Purcaro; Carmen Giannatonio; Patrizia Papacci; Costantino Romagnoli

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5859. doi:

ARVO Annual Meeting Abstract March 2012

Fluorangiographic Study of Retinal and Choroideal Vasculature in a Preterm Population

Domenico Lepore; Monica M. Pagliara; Antonio Baldascino; Lorenzo Orazi; Salvatore Luceri; Pierdavide Perrini; Guglielmo D'Amico; Carmine Angora; Ferdinando Lafranceschina; Fernando Molle

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5860. doi:

ARVO Annual Meeting Abstract March 2012

Screening for ROP:16 years experience

Lorenzo Orazi; Domenico Lepore; Antonio Baldascino; Salvatore Luceri; Pierdavide Perrini; Guglielmo D'Amico; Monica M. Pagliara; Fernando Molle

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5880. doi:

ARVO Annual Meeting Abstract April 2011

Retinal Functional Changes Measured by Microperimetry in Choroidal Melanoma Treated with Ruthenium Episcleral Plaques

Monica M. Pagliara; Maria A. Blasi; Michela Laguardia; Carmela Grazia Caputo; Paolo Di Nicola; Maria Grazia Sammarco; Mariangela Gari; Emilio Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3279. doi:

ARVO Annual Meeting Abstract April 2011

ERG and Visual Acuity In Preterm Babies

Domenico Lepore; Fernando Molle; Monica M. Pagliara; Lorenzo Orazi; Eliana Costanzo; Carmine Angora; Antonio Baldascino; Salvatore Luceri; Ferdinando Lafranceschina; Benedetto Falsini

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3135. doi:

ARVO Annual Meeting Abstract April 2011

Intravitreal Injection of Bevacizumab Vs. Conventional Laser Treatment in Type 1 ROP

Fernando Molle; Domenico Lepore; Antonio Baldascino; Carmine Angora; Lorenzo Orazi; Monica M. Pagliara; Carmen Giannantonio; Velia Purcaro; Patrizia Papacci; Costantino Romagnoli

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3143. doi:

ARVO Annual Meeting Abstract April 2010

Beyond Intravitreal Injection of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy

G. d'Amico; T. Caporossi; M. M. Pagliara; F. Molle; D. Lepore; F. Focosi; E. Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4953. doi:

ARVO Annual Meeting Abstract April 2010

Correlation Between Clinical, Ultrasound Features and Pathologic Findings for the Diagnosis of Ciliary Body and Iris Tumors

M. M. Pagliara; M. A. Blasi; C. G. Caputo; M. G. Sammarco; G. Savino; E. Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5152. doi:

ARVO Annual Meeting Abstract April 2010

Choroidal Circulation in Severe ROP

L. Orazi; D. Lepore; F. Molle; C. Angora; M. M. Pagliara; F. Lafranceschina; A. Baldascino; G. D'Amico; S. Luceri; F. Focosi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5907. doi:

ARVO Annual Meeting Abstract April 2010

Is Early Treatment for Retinopathy of Prematurity Really Effective?

F. Molle; D. Lepore; M. M. Pagliara; C. Angora; A. Baldascino; F. Lafranceschina; L. Orazi; G. D'amico; S. Luceri; F. Focosi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5912. doi:

ARVO Annual Meeting Abstract April 2010

Correlation Between Fluorescein Angiographic Macular Findings and Visual Outcome in Severe ROP

D. Lepore; M. M. Pagliara; A. Baldascino; C. Angora; F. La Franceschina; L. Orazi; S. Luceri; F. Molle; D. Ricci; E. M. Mercuri

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5916. doi:

ARVO Annual Meeting Abstract April 2009

New Pattern for ROP Laser Treatment Under Fluorescein Angiography Control

D. Lepore; F. Molle; A. Baldascino; M. M. Pagliara; C. Angora; F. Lafranceschina; L. Orazi; G. D'Amico; F. Focosi; E. Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3138. doi:

ARVO Annual Meeting Abstract April 2009

Anatomical and Structural Outcomes After Vitrectomy in ROP Stage 4b and 5

A. Baldascino; D. Lepore; F. Molle; F. Focosi; C. Angora; L. Orazi; M. M. Pagliara; D. Ricci; F. Gallini; E. Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3159. doi:

ARVO Annual Meeting Abstract May 2008

Is It Worth to Remove the Lens During Vitrectomy for Stage 4b and 5 ROP?

C. Angora; L. Orazi; D. Lepore; F. Molle; M. M. Pagliara; G. D'Amico; A. Baldascino; M. Laguardia; F. Lafranceschina; E. Balestrazzi

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1391. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Convolutional Neural Network Based on Fluorescein Angiography Images for Retinopathy of Prematurity Management

Photodynamic therapy for the treatment of choroidal metastasis: a retrospective study

Correlation of clinico-pathological features and whole-genome sequencing analysis by array CGH for uveal melanoma

Adjuvant high-dose rate (HDR) brachytherapy for ocular tumours with orbital invasion

EDI-OCT for early evaluation of recurrence after ruthenium brachitherapy for choroidal melanoma

Brachytherapy with Iodine 125 or Ruthenium 106 for treatment of choroidal melanomas measuring 5-7 mm in thickness

Evaluation of the Effects of Intravitreal Injection of Bevacizumab on Controlateral Eye Treated with Conventional Laser Photoablation

Fluorangiographic Study of Retinal and Choroideal Vasculature in a Preterm Population

Screening for ROP:16 years experience

Retinal Functional Changes Measured by Microperimetry in Choroidal Melanoma Treated with Ruthenium Episcleral Plaques

ERG and Visual Acuity In Preterm Babies

Intravitreal Injection of Bevacizumab Vs. Conventional Laser Treatment in Type 1 ROP

Beyond Intravitreal Injection of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy

Correlation Between Clinical, Ultrasound Features and Pathologic Findings for the Diagnosis of Ciliary Body and Iris Tumors

Choroidal Circulation in Severe ROP

Is Early Treatment for Retinopathy of Prematurity Really Effective?

Correlation Between Fluorescein Angiographic Macular Findings and Visual Outcome in Severe ROP

New Pattern for ROP Laser Treatment Under Fluorescein Angiography Control

Anatomical and Structural Outcomes After Vitrectomy in ROP Stage 4b and 5

Is It Worth to Remove the Lens During Vitrectomy for Stage 4b and 5 ROP?

To View More...

You must be signed into an individual account to use this feature.